Several "staging" imaging studies may be done to help determine whether the cancer has spread beyond the breast and regional lymph nodes. These may include: Bone scan CT of the chest, abdomen, and pelvis PET Although surgery (lumpectomy or mastectomy) or radiation therapy may occasionally be ...
Surgery is considered primary treatment for early-stage breast cancer; many patients are cured with surgery alone. The goals of breast cancer surgery include complete resection of the primary tumor with negative margins to reduce the risk of local recurrences and pathologic staging of the tumor and...
Cooper DButterfield J Pregnancy subsequent to mastectomy for cancer of the breast. Ann Surg. 1970;171429- 433Google ScholarCrossref 95. Petrek J Safety of pregnancy after breast cancer: are the data reliable? [editorial]. Medscape Women's Health eJournal [serial online]. 1997;2Available ...
Cite this: Inorganic Nanoparticles for Predictive Oncology of Breast Cancer - Medscape - Jan 01, 2009. Abstract and Introduction NPs in Breast Cancer NPs for Ultrasensitive Detection of Breast Cancer NPS for Biomolecular Profiling of Breast Cancer NPs in the Surgical Treatment of Breast Cancer NPs ...
Sacituzumab govitecan (SG) is an anti-Trop-2 antibody-drug conjugate with an SN-38 payload. In the ASCENT study, patients with metastatic triple-negative breast cancer (mTNBC) relapsed/refractory to ≥2 prior chemotherapy regimens (≥1 in the metastatic
Volkmar Müller reports speaker honoraria from AstraZeneca, Daiichi-Sankyo, Eisai, Gilead, high5 Oncology, Medac, Medscape, MSD, Novartis, Onkowissen, Pfizer, Pierre Fabre, Roche, and Seagen; consultancy honoraria from Amgen, ClinSol, Daiichi-Sankyo, Eisai, Gilead, Lilly, MSD, Novartis, ...
Whereas breast cancer diagnosis is largely based onhistopathologic assessment,disease stagingis largely reliant on imaging. Imaging also plays an essential role intreatment selection and monitoring. There are variousimaging modalitiesused to assess disease severity and response to treatment in patients with...
Florida) — In women with stage I/II breast cancer who have clinically negative axilla, "sentinel lymph node biopsy [SLNB] is now the standard of care" in staging these nodes, said Robert Carlson, MD, during the breast cancer guideline update here at the National Comprehensive Cancer Network...
The Pan-Asian panel of experts agreed with and accepted completely (100% consensus) the ESMO recommendations on staging and risk assessment ‘recommendations 2a-m’ below and in Table 1. 3. HR-positive, HER2-negative breast cancer—recommendations 3a-r An algorithm for the treatment and managemen...
Axillary lymph node status at the time of diagnosis is the most important prognostic indicator for women with breast cancer, and may influence management decisions. However, at present its role is controversial, as some groups recommend avoiding axillary lymph node dissection (ALND) in cases with ...